Capsule Endoscopy for Portal Hypertensive Enteropathy

Abstract EN

Portal hypertensive enteropathy (PHE) is a mucosal abnormality of the small bowel that is observed in patients with portal hypertension (PH) and can lead to gastrointestinal bleeding and anemia.

The pathogenesis is still not completely understood.

The introduction of new endoscopic methods, including capsule endoscopy (CE) or balloon-assisted enteroscopy, has increased the detection of these abnormalities.

CE can also serve as a road map for deciding subsequent interventions and evaluating the treatment effect.

The prevalence of PHE is reportedly 40–70% in patients with PH.

Endoscopic findings can be roughly divided into vascular and nonvascular lesions such as inflammatory-like lesions.

Traditionally, PHE-associated factors include large esophageal varices, portal hypertensive gastropathy or colopathy, Child-Turcotte-Pugh class B or C, a history of variceal treatment, and acute gastrointestinal bleeding.

More recently, on using scoring systems, a high computed tomography or transient elastography score was reportedly PHE-related factors.

However, the prevalence of PHE and its related associated factors remain controversial.

The management of PHE has not yet been standardized.

It should be individualized according to each patient’s situation, the availability of therapy, and each institutional expertise.